Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106995807A enables high-purity Sitagliptin intermediate synthesis via recombinant transaminase, offering supply chain stability and cost efficiency.
Patent CN109053387B details a novel two-step Magnolol synthesis using NbCl5 catalysis. This route offers mild conditions, high selectivity, and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN119431242A reveals Ir-catalyzed cycloaddition for high-purity intermediates. Enables cost reduction and scalable supply for global drug development.
Patent CN104610216B reveals a one-pot cascade synthesis for 6H-benzo[C]benzopyrans. This method offers significant supply chain and cost advantages for pharmaceutical intermediates.
Patent CN107162970A reveals ionic liquid catalysis for high-purity quinolone derivatives. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102153500B reveals a continuous fixed-bed method using acid-modified H-beta zeolite for high-yield diindolylmethane production, offering significant cost and efficiency advantages.
Patent CN116947600B reveals atom-economic synthesis for valproic acid impurity control. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN104761599B details a novel synthesis route for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable manufacturing.
Novel ionic liquid catalyzed synthesis ensures high purity and scalable production for advanced battery electrolyte manufacturing supply chains.
Novel palladium-free synthesis of vortioxetine intermediates ensures high yield and supply chain reliability for global pharmaceutical manufacturing partners.
Analysis of patent CN110818573A reveals mixed-acid catalysis improves MOCA yield and reduces wastewater, offering cost-effective supply chain solutions for polymer manufacturers.
Patent CN111646958B reveals a novel organocatalytic route for carfilzomib intermediates, offering high purity and cost-effective manufacturing solutions for global supply chains.
Patent CN110372755B reveals a stable Pd-carborane catalyst for efficient arylamine formylation, offering high yields and green processing for pharma intermediates.
Patent CN101519403B reveals ionic liquid microwave synthesis for tioconazole. Offers high yield, green chemistry, and supply chain advantages for pharmaceutical intermediates.
Patent CN108753851B details a novel ChKRED12 enzyme method for producing high-purity chiral 1,2-diols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel catalytic method reduces thionyl chloride usage significantly. High purity 99% yield 92.5%. Reliable pharmaceutical intermediates supplier for Sofosbuvir chain.
Discover a novel high-yield synthesis for S-pantoprazole sodium using sodium bismuthate. Enhanced optical purity and cost-effective manufacturing for global supply chains.
Novel patented process for Pranoprofen utilizing phase transfer catalysis and ultrasonic seeding to enhance yield and purity for pharmaceutical manufacturing.
Patent CN100532360C reveals a novel method for chlorpyrifos intermediates, reducing costs and improving supply chain reliability for agrochemical manufacturers globally.
Patent CN111253413A details a green Nb2O5 catalytic route for isosorbide. Achieve >85% yield with reduced waste. Ideal for pharma and polymer intermediates.